Eli Shalom

Eli Shalom serves as CTO at Isotopia. Isotopia operates in the pharmaceuticals sector with approximately 97.0 employees.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,464 c suite-level executives.

Outlook Facebook Login (Connect) WordPress.org Apache Google Font API DoubleClick Conversion Google Analytics DoubleClick Google Tag Manager Facebook Widget Linkedin Marketing Solutions Mobile Friendly Nginx Google Dynamic Remarketing Hubspot Facebook Custom Audiences

lu177 production centralized radiopharmacy cold kits production sterile plant theranostics oncology nuclear medicine molecular imaging radiopharmaceuticals cmo isotopes petct pharma pharmaceuticals contract manufacturer organization pharmaceutical manufacturing lutetium-177 diagnostic isotopes therapeutic isotopes pet products spect products cold kits isoprotrace kit aseptic manufacturing contract manufacturing organization cmo services patient care cancer diagnosis cancer treatment precision medicine quality control gmp-compliant clinical trials sterile drug production radiopharmacy advanced imaging isotope supplier lifecycle solutions supply chain management quality assurance healthcare providers innovative solutions patient outcomes advanced technologies health safety radiotracers lutetium production fda compliant european marketing authorization global reach patient access isotope production tailored solutions custom manufacturing real-time tracking microbiology laboratories rapid delivery advanced facilities customer-centric approach sustainability operational excellence breakthrough therapies hospital & health care medical health care health wellness & fitness logistics & supply chain environmental services renewables & environment

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Eli Shalom in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Isotopia.

Eli Shalom's Position in the MessageCEO Database

• •Eli Shalom is 1 of 1 verified executive contact we track at Isotopia.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •3 verified contacts work at pharmaceuticals companies in the 97.0 employee range (same size as Isotopia).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

How do I reach Eli Shalom directly?

Eli Shalom's verified email address is available to MessageCEO Pro subscribers. They currently serve as CTO at Isotopia. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Eli Shalom work for?

Eli Shalom is CTO at Isotopia, a company in the pharmaceuticals sector with 97.0 employees.

Can I pitch or sell to Eli Shalom?

As CTO at Isotopia, Eli Shalom is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Eli Shalom directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Eli Shalom in?

Eli Shalom works in the pharmaceuticals industry as CTO at Isotopia. MessageCEO provides verified contact information for executives across all major industries.

Is Eli Shalom's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Eli Shalom's profile is kept up-to-date with the latest available information.

Last updated: November 1, 2026